Targeted therapies for solid tumors: is the dream becoming a reality?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Works matching IS 17762596 AND DT 2006 AND VI 1 AND IP 3
Results: 7
1
2
Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 123, doi. 10.1007/s11523-006-0022-5
- By:
- Publication type:
- Article
3
Hypertension and targeted therapy.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 172, doi. 10.1007/s11523-006-0024-3
- By:
- Publication type:
- Article
4
Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 114, doi. 10.1007/s11523-006-0023-4
- By:
- Publication type:
- Article
5
Reovirus and other oncolytic viruses for the targeted treatment of cancer.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 130, doi. 10.1007/s11523-006-0026-1
- By:
- Publication type:
- Article
6
Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 151, doi. 10.1007/s11523-006-0025-2
- By:
- Publication type:
- Article
7
Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 3, p. 168, doi. 10.1007/s11523-006-0021-6
- By:
- Publication type:
- Article